ArticleBlood advances2022

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.

Kai Rejeski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.